Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Europe. The aim of this observational study is to evaluate glycaemic control in subjects with type 2 diabetes using once daily Levemir® as initiation of insulin therapy in Hungary.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Hypoglycemic Agents; Insulin; Insulin Detemir; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Patient with type 2 diabetes inadequately controlled by OAD therapy based on the discretion of individual physician

• Patient willing to sign informed consent

• Particular attention should be paid to age limits, indications and contraindications and the drug interactions that are listed within the product labels

Exclusion Criteria:

• Subjects with diagnosed type 1 diabetes mellitus

• Subjects who are unlikely to comply with observational plan, (e.g., uncooperative attitude, inability to return for further visits)

• Subjects with hypersensitivity to Levemir® or to any of the ingredients

• Women of childbearing potential, who are pregnant, breast-feeding or intend to become pregnant within next 12 months.